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ABSTRACT
This technical report presents the results from a special
physiological study of women performed at the Johnson Space
Center in 1976-77. The purpose was to establish a substantially
large (98 subjects) normative data base taken from a general
population of working women who might be considered
representative of future women astronauts. The data sets consist
of medical historical, clinical, anthropometric, and stress
response determinations and measurements which would be relevant
to human space flight and hence helpful in establishing
appropriate medical screening criteria (types of tests and their
normal values) for selecting women astronauts. The stressors
chosen were lower body negative pressure and static standing
(both orthostatic) and treadmill exercise (ergometric). Most
methods were identical to or similar adaptations of those
protocols used in testing Apollo and Skylab program crewmen.
Data are provided in two formats: (I) original individual values
which are amenable to cross correlations and subsequent analyses
in any subsets which might be of interest and (2) statistical
summaries and correlations suggested by the variables themselves
and by certain questions which concern investigators of the human
responses to microgravity. Of notable comment is the very great
similarity of many characteristics of the women subjects of this
study generated before selection of any American women astronauts
and the corresponding characteristics of those women astronauts
now regularly flying among Shuttle space crews.
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Concerns for the physiological responses of women did not appear
in NASA operations until after the historic Skylab missions. In
a symposium held in August, 1974, the National Aeronautics and
Space Administration reported medical results (25) of its three
successful Skylab missions, which had concluded with the 84-day
mission on February 8, 1974. In July, 1975, the last of the
Apollo-class missions was flown jointly with the Soviet Soyuz 19
mission (35). At this point in time no American women had ever
been selected as astronauts. The next U. S. program involving
humans in space, however, was to employ the reusable Space
Shuttle in which many more individuals with widely varying
disciplines and physiological states were envisioned to be among
the crews. Women were to be included in the next astronaut
selection which took place in 1978. This was the eighth serial
group selected by NASA beginning with the first cohort of seven
Mercury astronauts.
Thus, early in 1976 a study was initiated at the Johnson Space
Center to determine, from a selected group of women, baseline
physiological responses which would be pertinent to human space
flight. It was intended that results from that work might
contribute to medical design of the subsequent selection
process, both in the choice of screening tests and in determining
reasonable envelopes of normal values for women. It could also
serve as reference for future studies.
Somewhat prior to the study reported here, due to a host of
factors, a newly found, generalized interest in the physiological
and medical study of women had appeared. Among emphases of these
studies were exercise and physical fitness, menstrual variations,
and body composition. Quite specific questions were addressed
elsewhere relative to the similarities of, or possible
differences between, men and women in their responses to the
environment of space. The first of a series of studies of
specially selected women under simulated microgravity (bed rest)
was conducted by investigators at the NASA Ames Research Center,
Moffett Field, California, beginning in 1973 (39). Additional
specific work was subsequently performed at the Ames Research
Center, at the NASA Kennedy Space Center, and elsewhere, to
refine the responses of women to orthostatic stressors
(13,14,15,17,18,23,26,31,34,39,45). Some of these and other
studies have measured responses of women to exercise with
particular focus on probable responses to weightlessness
(6,7,8,9,12,16,20,27,30,39,41,46,47). Meanwhile several American
women astronauts have flown on Space Shuttle missions to give us
both subjective and objective documentation of their resiliency
to this new environment (40).
Nevertheless, this data set, not heretofore accessible in the
public domain, is here reported because it represents one of the
earliest space oriented (with emphasis on microgravity) data
bases and is perhaps the largest such grouping using a common
protocol. In addition, it yielded many biological
measurements of human responses to two major stressor
protocols relevant to weightlessness--orthostasis (by erect
standing in earth gravity and by lower body negative
pressure) and ergometry (by motorized treadmill). Finally, it
consisted of a diverse group of healthy women employees at the
Johnson Space Center who were considered to be broadly
representative not only of American women but also of future
women astronauts (2) (age, life style, body habitus, physical
condition, reproductive status, work and medical history, etc.).
METHODS
Ninety-eight volunteer women subjects between the ages of 21-61
years were solicited from the work force of the Johnson Space
Center. Review of their medical record, laboratory data, and an
interim medical status questionnaire were used to assure absence
of any clinical condition which would contraindicate their
participation in either a lower body negative pressure (LBNP) or
a treadmill exercise (TMX) stress test. Their use of replacement
estrogen hormones, thyroid, oral contraceptives, or cigarettes
was permitted. No prescreening of fitness level by stress
testing was determined, but a three-scaled historical assessment
of their usual activity level was obtained. None had previously
participated in research studies in these laboratories.
Descriptive Historical and Clinical Data
Age, height and weight clothed but without shoes (recorded with
calibrated clinical scales in English units, and later converted
to metric), oral and room temperatures (using clinical and
laboratory mercury in glass thermometers calibrated in
Centigrade, with Fahrenheit values converted from a nomogram),
and pulmonary functions were taken on the morning of, but prior
to, each test. Body surface area was computed from the formula
of Dubois (ii). Hemoglobin, hematocrit, cholesterol,
triglyceride, and clinical blood pressure values (within the
past 12 months) were abstracted from their clinical records.
Hours of sleep the previous night, hours since last eating,
smoking and exercise history, current medications, and day of
their current menstrual cycle with usual cycle length (or
hysterectomy or postmenopausal state, if applicable) were
recorded.
LBNP Stress Test
A graded LBNP stress test identical to that used on Apollo and
Skylab crewmen was employed (22,24,25). Its protocol allowed
five minutes of supine rest, fifteen minutes of incrementally
reduced pressure applied below the level of the iliac crest
(unless presyncope caused premature termination of the full
protocol), and five minutes of recovery back at ambient pressure
(see Figure L). Prior to initiation of each test, baseline
suplne blood pressure, maximal calf circumferences (both), and
volume of the left leg by the method of serial circumferences
(22,24) were measured (See Figure V).
Appropriate non-invasive sensors provided heart rate from a
Frank-lead orthogonal electrocardiogram; systolic and diastolic
blood pressure from an automatically cycled arm cuff with
microphone positioned over the left brachial artery to pick up
Korotkov sounds; change in left and right calf volume (percentage
change from control values) using a calibrated, double-stranded,
mercury-in-silastic strain gauge; and systolic time intervals
(STI) from the electrocardiogram, a phonocardiogram (20 gram
Elema EMT-25C piezo-electric crystal accelerometer), and a
carotid pulse trace (Sanborn/Hewlett Packard APT-16 displacement
transducer). A pneumogram (thoracic mercury in silastic strain
gauge) provided respiratory status to assure that all analyzed
STI's were taken in the expiratory phase. At least 3 cardiac
cycles, not necessarily consecutive, were used to determine the
measurement for each state of condition. Reduction of STI data
was performed with a Tektronix 4014 terminal using an interactive
program of in-house design. All systems were functionally
identical to those used on the Skylab LBNP studies (24).
For statistical analyses and reporting, dynamic data were used
only from the resting and the highest attained level of LBNP
(average of values, respectively, in the fifth minute of rest and
in the fifth minute of -50 mm Hg phase of LBNP, except when
presyncope intervened).
Treadmill Stress Test
Approximately 30 minutes after completion of the LBNP test, each
subject underwent a graded treadmill exercise stress test
similar to the Balke protocol using a speed of 3.3 mph and
grade increments of 5 % with 3 minutes at each grade. Prior to
each treadmill test, supine (after 5 minutes) followed by
standing (after 8 minutes) heart rate and systolic and diastolic
blood pressures were taken for comparison with the LBNP data.
Dynamic heart rate, systolic and diastolic blood pressures,
and oxygen consumption (with a CPI 5000 metabolic analyzer)
were measured at the subject-limited, voluntary exertional
effort (Quinton treadmill, model 1860) targeted for the maximal
predicted heart rate. Time on the treadmill to that point
was also recorded. Statistical analyses of these dynamic
data were performed for the last minute of standing at rest, at
the time of maximal effort, and for the second and the fifth
minutes of recovery (supine). Signals for determining systolic
time intervals (according to the same techniques used
during LBNP) were taken in the supine position before
initiation of the exercise protocol and as soon as
possible (1-2 minutes) after maximal performance had been
achieved.
Duplicate Tests for Reproducibility
After the primary data base had been established, identical
protocols were conducted again on seventeen of these subjects who
returned to the laboratory from two weeks to six months after
their first testing. This provided a measure of reproducibility
both from laboratory-team technique and from possible inherent
changes over time. The inclusive dates for generation of data
for this study were 13 October, 1976, through 26 April, 1977.
Statistical Analyses
Descriptive statistics were obtained for all numerical variables.
These included mean, standard error of the mean, and minimal and
maximal values. Pearson correlation coefficients were obtained
for every pair of variables within the three grouped sets, and
for selected pairs of variables between the sets. Variables
which showed correlation significantly different from zero were
further analyzed using simple linear regression models to assess
the predictive capabilities for one set of variables toward the
other. For test-retest comparisons the Student's t-test was
used. All computations were performed with the SAS statistical
package of SAS Institute, Inc., Cary, North Carolina, using a
significance level of alpha = 0.05 for each test of hypothesis.
RESULTS AND DISCUSSION
Archival Data
Values of test variables for each individual subject are
tabulated (Appendix) by grouping according to type: subject
descriptors, ambient conditions, medical and historical
information, clinical measurements, LBNP and TMX stress protocol
responses, and certain anomalous events (Tables I through VIII).
Subject numbers provide positive identification to allow any
interrelationship of individual subjects and variables.
Parallel tabulations of data from those 17 subjects who underwent
two sequences of tests are given in Tables IX through XV. Note
that each subset is ordered identically so that each two
corresponding lines of data derive from the same subject (i.e.,
subject number 22 = subject number 142, etc.). Direct
comparisons may be seen by the computed means and standard errors
of the mean from each test set.
Systolic time intervals were measured at supine rest and
during maximal stress with the LBNP protocol and in the supine
position before and after exercise with the TMX protocol. The
pre-ejection period/left ventricular ejection time (PEP/LVET or
just STI) ratios with their corresponding instantaneous heart
rates are listed for the two protocols in Tables XVI and XVII,
respectively.
Table XVIII provides calculated percentage changes for four major
measures of stress (both LBNP and TMX) at their maximal response
values using the respective resting value as reference: heart
rate, systolic and diastolic blood pressures, and the systolic
time interval ratios.
Table XIX gives double products (heart rate multiplied by
systolic blood pressure) calculated whenever data permitted
in the supine, resting position both before LBNP and before
TMX, at maximal LBNP and during quiet standing (before TMX), as
soon as possible after the TMX maximal effort, and at 2 and at 5
minutes after TMX (both supine).
Missing data occur in several tables. Omissions in
table are due to either of three factors: data not




Tables AI, BI, and C1 present for descriptive, LBNP test, and
TMX test variables, the number of subjects contributing valid
data for that variable, overall mean values, the standard errors
of the means, and minimal and maximal values for each variable.
For the most part, variables are presented in these tables in the
same order of descriptive, LBNP, and TMX data sets given in the
archival tables for individual subjects.
Tables A2, B2, and C2 present correlations (linear regressions),
together with slopes and intercepts, between all pairs within the
respective groups of variables in Tables AI, BI, and Cl which
met statistical significance.
Tables D and E likewise present additional similar correlations,
together with slopes and intercepts, between LBNP and TMX test
variables, respectively, paired with other descriptive variables,
and meeting the same statistical significance.
Table F shows statistically significant correlations between
selected TMX and LBNP test variables paired as indicated.
Table G displays number of subjects contributing data, means,
standard errors of the means, and minimum-maximum ranges for
double products taken at several states of the two stress
protocols.
Table NWA (courtesy of Edward C. Moseley, Ph.D., Johnson Space
Center, Houston, Texas) is a recent (ca. 1987) compilation of
several pertinent descriptive variables from current women
astronauts resident at the Johnson Space Center. These data are
provided primarily to allow comparisons between present women
astronauts and similar variables of this data base, originally
generated in anticipation of their selection.
The marked similarities between current women astronauts and
subjects of this study group tested over a decade earlier is
quite striking. This is evident from the considerable
correspondence between mean values of variables given for these
astronauts and those same variables (see Tables A1 and Cl) of
the rather heterogeneous group of women employees at the Johnson
Space Center who were the subjects of this study. It is more
remarkable since members of the study group were not so much
selected as they were a volunteer sample of the women work force.
That they so well represent, both physiologically and clinically,
our present astronauts warrants use of this data base for
comparisons with or projections to women exposed to the space
environment.
Figures 1 through 6 show several statistically significant linear
correlations among this subject group for pairs of variables
reasonably expected to have shown such relationships (see also
respective discussions below):
I. Heart rate at maximal treadmill exercise versus age
2. Peak oxygen uptake versus heart rate at maximal exercise
3. Peak oxygen uptake versus duration of exercise
4. Heart rates at maximal LBNP (-50 mm Hg) versus standing
5. Systolic blood pressures at maximal LBNP (-50 mm Hg)
versus standing
6. Mean blood pressures at maximal LBNP (-50 mm Hg) versus
standing.
The relatively large number of subjects contributing to these
curves enhances the validity of their mathematical parameters.
Analytical Data and Findinqs
Repeatability of Test Measurements
Before attempting to understand the overall study results, an
appreciation of the repeatability of test results under the
circumstances of protocols used here is helpful (Tables IX
through XV). This merges the inevitable variability of human
subjects (a large component of this may be in the fact that no
training or familiarization sessions preceded actual data taking
tests), the inherent limits of hardware systems, certain
variations or inconsistencies between different scientists and
technicians who prepare and monitor subjects, and possible
seasonal, training, and/or other factors which can introduce
trend differences.
In general, descriptive and non-stressed data showed no change
between the two mean values separated in time, even though
individuals may have inexplicably large variations in
measurements which can best be attributed to technique (e.g.,
height of subject 22 decreasing over 4 centimeters between her
clinical measurement on i0 Dec 76 and that taken on her as
subject 142 on 12 Apr 77; was it an error of converting to
metric units; did she wear shoes, etc.?). Mean room
temperatures also did not
the winter months when






Unfortunately, duplicate clinical blood/chemistry data were not
often available and pulmonary function data were not repeated.
All mean heart rate and blood pressure values for the first LBNP
test were higher than those of the second test. These, however,
were statistically significant only for diastolic pressure
readings and for the supine resting systolic values from the LBNP
protocol. This may well be attributed to the general anxiety
attendant a new, unknown experience encountered for the first
time. None of the leg dimensional mean values differed between
the two tests.
Like that for the LBNP protocol, supine resting systolic blood
pressure taken at the first TMX test was significantly greater
than that of the second test. Other blood pressure values
between the two TMX tests showed no differences, probably due to
the overriding effect of the metabolic stimulus of exercise which
obscures a lesser effect of anxiety. On the other hand, several
mean values from the TMX tests were greater for the second test;
heart rate at the second minute of recovery from treadmill
exercise, maximally achieved oxygen consumption and duration on
the treadmill were significantly elevated. These may be
attributed to gains from familiarization effects of the first
test, both for the subjects as well as for the laboratory
test team, resulting in a greater maximal volitional effort for
the second test.
Specific Determinations
The descriptive information shown in Tables I, II, IX, X, and A1
fully supports the assertion that the subjects of this study were
normal, healthy, and reasonably representative of middle-aged
active women (7,8,12,14,15,17,27,39,43,46,47). Of the 71 who
were regularly menstruating, 31 (44%) were using oral
contraceptives. One on oral contraceptives had highly irregular
menstrual periods. Of the remaining 26, nine (35%) had begun or
completed menopause and 17 (65%) had had hysterectomies.
At the outset of this study a concern had been voiced that women
may evidence dissimilar orthostatic responses at different times
in their menstrual cycle. This concern was supported by clinical
alterations, both subjective and physiological, which might
predispose to alter orthostatic intolerance. Mechanistically,
with greatest fluid retention occurring premenstrually
(38,42,44), maximal orthostatic tolerance would be predicted at
this phase.
Thus, even though the design of this study was cross-sectional,
it was reasoned that a large number of women tested at random in
their menstrual cycles would reveal such a relationship if it
existed. A potential confounding of this thesis was the large
number of regularly menstruating women using oral contraceptives(42) .
In any case, no specific correlations of LBNP or TMX responses to
phase of menstrual cycle (determined as the ratio of cycle day to
cycle length for the time axis) were determined. Several studies
since that time have demonstrated no differential responses of
the cardiovascular system which would suggest functional or
performance deficits due to phase of menstrual cycle
(9,12,13,16,17,20,30,39,41,43). On the other hand, it is more
likely that high levels of regular physical activity may affect
and even disrupt the normal menstrual pattern (3,4,36).
Many of the statistical correlations in Table A2 are expected
because of the interaction of the paired variables, but some
more likely have physiological meaning: the known relationships
of age, and the direct correspondence of height and weight with
pulmonary function (especially vital capacity); the inverse
associations of body surface area with triglycerides and of
menstrual cycle length with diastolic blood pressure; and the
direct relations between age and cholesterol (well described in
medical literature), cholesterol and triglycerides, systolic
blood pressure and triglycerides, and body surface area and
clinical blood pressures. Some of these no doubt are related
mechanistically, but others must await further knowledge for a
rational explanation or may prove to be only coincidental random
statistical artifacts.
Certain mean values from Tables BI, Cl, and G warrant attention.
The correspondence among orthostatic stressors usually depends
upon the variable in question (32,33,49). As used with American
space crews, LBNP at -50 mm Hg has most closely evoked heart rate
elevations comparable to those observed in quiet standing when
referenced to those in the supine position (22). These two
independently applied stressors in this study have corroborated
this contention for heart rates, 74 to 88 beats per minute for
LBNP and 73 to 88 beats per minute for quiet standing. This
degree of equivalence from 98 women subjects is truly remarkable.
Graphical presentation of these data (Figure 4) further clarifies
this relationship. The slope is less than unity, although
identical heart rates occurred at the mean values for both
orthostatic stressors (during -50 mm Hg LBNP and during quiet
standing). Therefore, subjects who exhibited intrinsically lower
heart rates showed greater LBNP responses than for
standing; the converse was obtained for those with higher heart
rates. Hence, different responses to these two stressors seem to
be related to inherent or basal heart rate. Thus, individuals
with lower heart rates, likely manifesting a relative dominance
of parasympathetic control, seem more sensitive to LBNP, while
those with higher heart rates, presumably indicative of relative





An alternate way of stating this relationship is that
in heart rate for the gravitational gradient is
than for LBNP.
Mean systolic blood pressure decreased from supine rest to
maximal LBNP (104 to 95 mm Hg) while it increased from supine
rest upon upright standing in one gravity (104 to iii mm Hg).
The corresponding diastolic values for LBNP were unchanged (67
mm Hg) but for gravity were elevated (67 to 74 mm Hg). This
also resulted in differential orthostatic stressor responses for
the mean blood pressure: LBNP (slightly reduced from 79 to 76 mm
Hg) and gravity (increased from 79 to 86 mm Hg). (See Figure 6).
The disparity between blood pressure responses for these two
stressors has previously been noted (22). Its explanation is
still elusive, but likely originates in differential stimulations
of baroreceptors as well as varied regional distributions of
vascular volume (19). These qualitatively different pressure
responses to two orthostatic stressors likely contribute to the
similarity in the above described heart rate differentials and
probably in part account for alleged excessive and sometimes
adversely interpreted responses among more physically or
aerobically fit individuals (See Tables B1 and Cl and Figure 5).
It may well be reasoned that the body would not respond with all
its control systems identically to the stress of LBNP (a
discretely applied differential pressure at the iliac crest) and
to the stress of the gravitational vector (a smooth gradient from
foot to head). Indeed, that the heart rate or any other variable
(e. g., change in leg volume) should be so similar for the two
orthostatic conditions is perhaps fortuitous. The similarity of
such responses must result from integrative control mechanisms
which have thereby provided a predictive tool in LBNP for
testing human orthostatic tolerance in the absence of gravity.
The two other major components of cardiovascular dynamics, viz.,
blood flow and total peripheral resistance, were both unmeasured
here. Cardiac output is known to fall in both situations,
however, while peripheral resistance can be quite variable
depending upon the vascular region studied (13,14,15,19).
Supine resting heart rate was inversely correlated with change in
right leg volume, but directly and very highly with maximal heart
rate attained during LBNP. Both systolic and diastolic (resting
supine and maximal during LBNP) blood pressures were directly
correlated with maximal calf circumferences and left leg volume.
These findings (Table B2) likely have multiple explanations, with
contributions from both acute control mechanisms of the
cardiovascular system and from more long term controls of fluid
volumes. With relative sympathetic dominance (which would be
expected to manifest in higher supine resting heart rate and
higher blood pressures), a lesser increase in leg volume during
LBNP might suggest increased (neural or endocrine) peripheral
vascular tone. It could as well represent increased
intravascular, or extracellular in general, volume. In reality,
no single factor is likely the sole explanation for these
findings. The association of greater blood pressure values with
larger leg size is consistent with a diminished peripheral
compliance reflected within the vascular system. This also could
have contributions both from elements which determine vascular
wall tone and from factors controlling vascular volume.
Yet other measurements whose response is conditioned by several
interdependent factors are the systolic time intervals. The most
meaningful single measurement from these determinations is
probably the pre-ejection period/left ventricular ejection time
ratio (PEP/LVET or STI ratio); it also removes heart rate
dependency. The PEP is increased while the LVET is decreased by
diminished preload; both are decreased by positive inotropic
effects. Again the supine resting ratios are quite comparable
from both the LBNP and the TMX protocols (another form of
repeated measures), 0.292 and 0.283, respectively. Their
values in response to the stressors, however, differ
considerably; that during maximal LBNP increased to 0.419 while
that immediately following maximal TMX effort hardly
increased, 0.306. Of course, the hyperdynamic state induced
by exercise contributes to cardiac contraction an enhanced
inotropic factor as well as cardioacceleration. No doubt there
is also considerably greater cardiac return during exercise
as compared to that during LBNP, when cardiac return is
greatly reduced. This results in decreased preload which is
reflected in elevated PEP/LVET ratio (well correlated with the
left ventricular ejection fraction) during LBNP (28).
A similarly conditioned variable is the double product. This
measurement closely estimates the myocardial oxygen requirement
(21). Table G shows again the good repeatability of supine
resting mean values from both stressor protocols. However, the
corresponding values for the respective stressed states differ
notably; that for LBNP increased only 9 percent while that for
TMX increased 28 percent. The active mechanism here is probably
similar to that proposed above with respect to systolic time
intervals. It is evident that this value for exercise is about
three times greater than that evoked by orthostasis (LBNP or
gravity).
Fully expected and here substantiated were the high direct
correlation of maximally achieved TMX heart rate with oxygen
consumption (Table C2) and the inverse correlation of that heart
rate with age (Table E). An additional interrelated correlate
was the duration of exercise, which agreed well with both maximal
heart rate and peak oxygen consumption (Table C2).
Figures I, 2, and 3 present these relationships graphically. In
this well known age relationship (i), the women of this study
wrote the nomogram for volitional maximal exercise heart rate
equal to 207 - .78 x age. The relationship of oxygen uptake and
heart rate is also described as the oxygen pulse. Here the gain
is approximately one-fourth milliliter oxygen per kilogram body
i0
weight per heart beat per minute. Augmentation of oxygen uptake
with longer times of exercise reflects the greater metabolic load
sustained by these more fit subjects.
Tables D and E list other variables from the total data set which
correlated significantly with specific measurements generated
during the two stressor protocols. Also expected and observed
were the direct correlations of diastolic blood pressure with age
and of the peak oxygen consumption with habitual level of




This study has produced a large physiological data base generated
from women representative in many attributes of current women
astronauts. It has provided historical and clinical descriptive
values for the population subset and their characteristic
responses to two forms of orthostatic stress (lower body negative
pressure and standing in one gravity) and to treadmill exercise
stress, all of particular interest in the study of human
responses to exposure to microgravity.
Results from this study warrant comparison with similar data from
women astronauts who fly into space. These results may also
serve as a useful reference for other ground based studies of
women subjects which may use more advanced techniques and produce
measurements not made in this study. The presentation of data in
archival form allows subsequent evaluations not here entertained.
Findings determined from the present analyses, however, suggest
that women will exhibit responses to microgravity little if any
different from those of men, who were the focus of most earlier
studies performed. Further, a hypothesized differential response
of women to orthostatic stressors dependent upon the phase of
their menstrual cycle was not substantiated.
12
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The following tables contain data sets from
all 98 subjects:
Subject and Test Descriptive Data
Subject and Test Historical Data
Blood and Pulmonary Test Data
LBNP Test Heart Rate and Blood Pressure Data
LBNP Test Performance Data
Treadmill Test Heart Rate and Oxygen Use Data
Treadmill Test Blood Pressure Data








The following tables contain data sets from
17 subjects who underwent repeat tests (note that
the same subject holds the same position in each
subset; i.e., subject 22=142, subject l=143,etc.):
Subject and Test Descriptive Data
Subject and Test Historical Data
Blood and Pulmonary Test Data
LBNP Test Heart Rate and Blood Pressure Data
LBNP Test Performance Data
Treadmill Test Heart Rate and Oxygen Use Data





The following tables contain data sets from
all 98 subjects:
LBNP Test Systolic Time Intervals
Treadmill Test Systolic Time Intervals




The following tables contain statistical data











Summary Statistics of Descriptive Variables
Significant Correlations between Descriptive
Variables (p<0.05)
Summary Statistics of LBNP Test Variables
Significant Correlations between LBNP Test
Variables (p<0.05)
Summary Statistics of Treadmill Test Variables
Significant Correlations between Treadmill
Test Variables
Significant Correlations between LBNP Test
Variables and Selected Descriptive Variables
Significant Correlations between Treadmill
Test Variables and Selected Descriptive
Variables
Selected Significant Correlations between
Treadmill and LBNP Test Variables
Summary Statistics of Double Products
NWA
These data were furnished from the Johnson Space
Center, Houston, Texas, and presented in tabular
form:
Selected Descriptive Statistics of NASA
Women Astronauts
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The following figures depict aspects of protocols
used in this study:
L
V
The LBNP protocol used in this study was the
same as that used in the Skylab experiment
The method of multiple leg circumferences used







The following figures provide graphical display of
selected known relationships as they pertain to
this particular subject group:
Linear Correlation of Maximal Heart Rate
Attained during Treadmill Exercise versus Age
Linear Correlation of Peak Oxygen Uptake
versus Maximal Heart Rate Attained during
Treadmill Exercise
Linear Correlation of Peak Oxygen Uptake
versus Duration of Treadmill Exercise
Linear Correlation of Maximal Heart Rate
Attained during LBNP versus during Standing
Linear Correlation of Systolic Blood Pressure
at Maximal LBNP versus Standing Systolic
Blood Pressure
Linear Correlation of Mean Blood Pressure at
Maximal LBNP versus Standing Mean Blood
Pressure
15
KEY TO ABBREVIATIONS FOR VARIABLES NAMED IN THE TABLES
DISCRETE VARIABLES
SUBJ = subject number
T-oral = oral temperature (deg F)
T-room = room temperature (deg F)
BSA = body surface area (sq m)
MENSTRUAL HISTORY = cycle day/cycle length (days); if none,
PM = post-menopausal or HY = hysterectomy, followed by the
number of years prior to testing for this event
LIFESTYLE: smoke, l=yes, 2=no;
exercise, l=inactive, 2=moderately active, 3=very active
SLEEP TIME = hours of sleep during previous night
EAT TIME = h_urs since subject last ate
HGB = hemoglobin (gm %)
HCRT = hematocrit (%)
T-CHOL = total serum cholesterol (mg %)
TRIG = serum triglycerides (mg %)
FEV-I = forced expiratory volume (L) in 1 second
FVC = forced vital capacity (L)
FOF = FEV-I/FVC x i00 (%)
VC = vital capacity (L)
LBNP VARIABLES
HR-SUP = heart rate (bpm) following 5 min. supine, pre-LBNP
HR-MAX = heart rate (bpm) at maximal LBNP
S-CLIN = systolic blood pressure (mm Hg), sitting, from clinical
records
D-CLIN = diastolic blood pressure (mm Hg), sitting, from clinical
records
S-SUP = systolic blood pressure (mm Hg) after 5 min. supine rest
D-SUP = diastolic blood pressure (mm Hg) after 5 min. supine rest
S-MAX = systolic blood pressure (mm Hg) at -50 mm Hg (or maximal
attained) LBNP
D-MAX = diastolic blood pressure (mm Hg) at -50 mm Hg (or maximal
attained) LBNP
LCC = left calf circumference (cm) after 5 min supine
RCC = right calf circumference (cm) after 5 min supine
CHANGE LLV = % change in left leg volume from 0 to -50 mm Hg (or
maximal attained) LBNP
CHANGE RLV = % change in right leg volume from 0 to -50 mm Hg (or
maximal attained) LBNP
LLV = left leg volume (ml) at supine rest
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TREADMILL VARIABLES
HR-SUP = heart rate (bpm) after 5 min. supine rest, pre-test
HR-STN = heart rate (bpm) after 8 min. quiet standing, pre-test
HR-HYV = heart rate (bpm) after 20 sec. hyperventilation
HR-MAX = maximal heart rate (bpm) during treadmill test
HR-R2 = heart rate (bpm) at 2 min. recovery
HR-R5 = heart rate (bpm) at 5 min. recovery
V-02 = peak oxygen uptake (ml/kg/min) during treadmill test
DUR EXER = duration of exercise (min) on treadmill
S-SUP = systolic blood pressure (mm Hg) after 5 min. supine rest,
pre-test
D-SUP = diastolic blood pressure (mm Hg) after 5 min. supine
rest, pre-test
S-STN = systolic blood pressure (mm Hg) after 8 min. quiet
standing, pre-test
D-STN = diastolic blood pressure (mm Hg) after 8 min. quiet
standing, pre-test
S-MAX = systolic blood pressure (mm Hg) nearest maximal
level of treadmill test
D-MAX = diastolic blood pressure (mm Hg) nearest maximal
level of treadmill test
S-R2 = systolic blood pressure (mm Hg) at 2 min. recovery
D-R2 = diastolic blood pressure (mm Hg) at 2 min. recovery
S-R5 = systolic blood pressure (mm Hg) at 5 min. recovery
D-R5 = diastolic blood pressure (mm Hg) at 5 min. recovery
ARRHYTHMIAS
PAC = premature atrial contraction
PVC = premature ventricular contraction
SYSTOLIC TIME INTERVALS ST_ DATA
PEP/LVET (also STI) RATIO = pre-ejection period/left ventricular
ejection time
HR-INST = heart rate (bpm), instantaneous, from the complex used
for measuring STI
DOUBLE PRODUCT DATA
DPSUNP = supine, at rest prior to LBNP test
DPSUTM = supine, at rest prior to TMX test
DPLBNP = at maximal level of LBNP attained
DPSTN = standing, at rest prior to TMX test
DPTMX = at maximal level of TMX exercise
DP2 = at 2 minutes after maximal level of TMX exercise




















































TABLE I SUBJECT AND TEST DESCRIPTIVE DATA
TEST DATE AGE HEIGHT WEIGHT T-oral T-room BSA
years cm kg deg F deg F sq m
130ct76 25 163.0 46.7 98.2
8Nov76 25 163.0 55.8 98.6
12Nov76 48 172.0 62.6 98.0
19Nov76 24 163.0 48.5 98.0
22Nov76 36 166.0 61.7 98.2
23Nov76 22 156.0 46.3 98.2
24Nov76 35 163.0 59.0 98.4
2Dec76 24 165.0 56.2 98.4
3Dec76 36 163.0 57.2 98.2
6Dec76 24 158.0 47.6 98.2
7Dec76 35 163.0 49.9 98.0
8Dec76 45 173.0 59.0 98.2
9Dec76 22 158.0 74.8 98.4
13Dec76 37 165.0 54.4 98.2
14Dec76 23 165.0 54.0 97.8
15Dec76 27 158.0 46.3 97.8
16Dec76 27 155.0 61.2 98.4
17Dec76 61 158.0 49.9 98.4
20Dec76 28 164.0 68.0 98.0
21Dec76 24 160.0 45.4 97.6
4Jan77 22 168.0 60.0 98.2
4Jan77 26 165.0 64.5 99.4
5Jan77 37 159.0 53.6 98.0
6Jan77 32 168.0 53.5 98.0
7Jan77 51 161.0 63.3 98.0
10Jan77 40 164.0 62.2 98.0
llJan77 34 150.0 51.7 98.4
12Jan77 21 160.0 49.2 98.6
13Jan77 24 158.0 47.2 99.6
14Jan77 23 167.0 57.3 98.4
17Jan77 46 170.0 67.3 98.0
18Jan77 30 168.0 55.5 98.0
19Jan77 29 165.0 54.4 97.8
20Jan77 32 169.0 76.5 97.8
21Jan77 24 169.0 60.0 98.4
24Jan77 31 168.0 61.2 98.2
25Jan77 52 175.0 71.7 98.6
26Jan77 42 170.7 53.8 98.0
27Jan77 25 170.2 65.3 98.2
28Jan77 44 167.0 57.9 97.8
31Jan77 46 157.4 76.4 97.8
iFeb77 58 158.7 59.1 97.8
2Feb77 31 169.0 56.0 98.4
3Feb77 23 170.7 62.3 98.0
3Feb77 24 172.7 59.4 98.6
4Feb77 55 170.2 66.2 98.0
4Feb77 29 166.0 68.0 98.6
7Feb77 55 166.2 68.4 98.0




















































































































































TABLE I SUBJECT AND TEST DESCRIPTIVE DATA
TEST DATE AGE HEIGHT WEIGHT T-oral T-room
years cm kg deg F deg F
8Feb77 52 180.0 61.9 97.8
9Feb77 36 165.0 57.6 98.2
10Feb77 26 159.0 70.4 97.8
llFeb77 32 162.3 63.2 97.8
14Feb77 23 174.8 66.3 98.0
15Feb77 38 173.2 67.4 98.6
15Feb77 43 161.3 61.9 98.0
16Feb77 31 162.3 52.4 98.0
16Feb77 29 162.2 53.3 98.0
18Feb77 29 161.2 60.6 98.0
18Feb77 30 163.6 63.3 98.2
22Feb77 46 166.8 71.8 98.0
22Feb77 41 166.3 60.6 98.2
23Feb77 47 165.3 59.2 98.4
24Feb77 25 167.1 56.7 97.8
24Feb77 26 165.5 63.7 98.6
25Feb77 31 172.5 67.1 98.0
28Feb77 42 165.0 49.1 97.8
28Feb77 30 159.0 53.6 97.6
IMar77 41 163.4 53.4 97.8
IMar77 21 167.7 53.6 97.8
2Mar77 52 155.0 54.2 97.6
3Mar77 20 162.1 47.6 98.0
3Mar77 37 168.8 61.2 98.4
4Mar77 32 170.6 54.8 97.8
8Mar77 50 164.9 50.3 97.8
9Mar77 34 160.3 62.7 97.8
9Mar77 31 169.6 71.4 98.0
15Mar77 33 163.6 52.6 97.8
15Mar77 26 154.2 48.7 97.8
16Mar77 47 164.7 54.9 98.2
16Mar77 29 167.2 53.5 98.0
17Mar77 42 176.8 68.5 98.4
18Mar77 38 167.3 73.1 98.2
18Mar77 44 172.5 63.8 97.8
22Mar77 39 157.5 59.5 97.9
23Mar77 23 160.0 71.0 98.6
24Mar77 34 165.1 84.3 98.2
29Mar77 25 170.0 80.3 98.2
30Mar77 30 170.0 75.5 97.8
30Mar77 25 155.8 66.2 98.4
30Mar77 25 155.0 55.3 98.8
14Apr77 57 165.0 58.1 97.8
15Apr77 47 166.5 57.1 97.8
15Apr77 39 170.2 75.5 97.8
21Apr77 37 166.0 60.6 97.4
22Apr77 40 166.0 67.3 98.6
25Apr77 26 163.0 51.6 97.8






































































































TABLE II SUBJECT AND TEST HISTORICAL DATA
SUBJ MENSTRUAL HISTORY MEDICATIONS LIFE STYLE
















































































































































2 1 5.0 12.0
1 3 5.5 2.0
2 2 7.0 11.5
1 1 6.5 14.0
2 2 6.5 13.0
1 3 8.5 14.0
2 1 7.0 14.0
1 1 8.0 12.0
2 2 7.0 12.0
2 1 11.0 1.5
2 1 6.0 16.0
1 6.5 10.5
1 2 5.5 2.0
2 2 6.0 12.0
2 1 7.5 14.0
2 9.0 14.0
1 1 7.0 1.5
1 2 6.0 12.5
2 1 8.0 13.0
2 1 6.0 15.0
2 7.0 14.0
1 2 7.0 5.0
1 2 7.0 I0.0
1 2 7.5 13.0
1 2 6.5 16.0
1 2 8.0 12.0
1 2 9.0 13.5
2 3 5.5 1.5
1 1 7.0 12.0
2 1 6.5 12.0
2 1 7.0 15.0
2 2 6.0 2.0
2 2 8.0 14.0
1 2 5.0 9.5
1 2 7.5 12.5
1 1 8.0 12.0
1 2 6.0 13.0
1 2 7.5 15.0
2 1 7.0 2.5
1 2 5.0 12.5
1 2 6.5 2.0
1 3 7.5 2.3
2 2 8.0 13.0
2 1 6.0 11.0
2 3 8.0 12.5
2 2 8.0 15.0
2 3 8.0 2.5
1 2 7.0 Ii.0
20




























































































































































1 2 6.0 7.0
1 2 6.0 2.0
2 2 8.0 18.0
2 1 8.0 14.0
1 2 12.0 12.0
2 2 7.0 1.0
1 3 7.O 2.O
1 2 6.0 13.0
2 1 7.0 21.0
2 2 8.0 13.5
2 1 8.0 11.0
2 7.0 11.0
2 3 7.5 2.5
2 2 6.5 3.0
2 3 8.5 12.5
1 2 7.5 15.0
2 2 8.0 13.5
1 6.O 2.0
1 2 11.0 19.0
2 8.0 14.5
2 3 8.0 14.0
1 1 7.0 2.5
2 1 7.0 14.0
2 1 7.0 3.5
2 3 7.5 12.5
2 2 6.0 2.5
1 2 6.5 13.0
1 3 6.5 14.0
1 2 6.0 11.0
2 1 5.5 15.5
1 1 6.0 14.0
1 2 8.0 14.5
2 1 6.5 12.0
2 1 6.0 2.5
2 1 7.5 14.5
1 1 8.0 14.0
2 2 8.5 14.0
2 1 9.0 12.0
2 3 8.O 1.0
1 2 8.0 1.0
2 2 8.0 1.0
2 2 8.0 19.0
2 2 6.5 11.0
1 2 7.0 11.0
1 6.0 11.0
2 2 7.5 12.0
2 7.5 2.0
1 3 7.0 13.5
1 2 7.5 3.0
21






















































T-CHOL TRIG FEV-I FVC





175 116 3.10 3.61 85 3.39
182 113 3.18 3.25 97 2.92
256 117
247 59 3.08 3.52 87 3.55
181 63 2.59 2.98 86 2.65
185 56 3.37 3.84 87 2.96
149 63 3.25 3.88 83 3.67
215 78 3.25 3.65 89 3.67
267 86
180 87 2.04 2.35 86 3.39
227 43
175 52 3.57 3.88 92 3.78
147 108 2.16 2.63 82 2.53
149 65 2.86 3.25 88 2.89
163 51 3.76 4.08 92 3.78
226 61 2.55 2.70 94 2.69
160 44 2.74 3.10 88 3.00
150 I00
165 95 2.86 3.37 84 3.20
267 107 3.33 3.68 90 3.55
117 48 3.72 4.59 81 4.33
260 107 3.45 4.16 82 4.02
239 93 2.63 3.33 78 3.43
167 54 3.57 4.19 85 3.90
187 80 2.63 3.41 77 3.28
268 107 3.06 3.88 78 3.90
185 45 2.55 2.98 85 2.81
153 86 2.63 3.53 74 3.59
229 71 3.61 3.72 97 3.59
231 104 3.25 3.88 83 3.28
288 117 2.35 3.14 74 4.25
218 105 3.49 3.61 96 3.43
164 70 2.74 3.10 88 3.08
203 128 3.80 5.25 72 5.15
240 115 3.06 3.41 89 3.67
193 96 3.06 3.68 83 4.06
228 53 2.59 5.10 50 5.31
232 70 3.33 4.47 74 4.45
206 136 3.18 3.72 85 3.47
191 52 3.02 4.04 74 3.78
199 105 2.27 2.98 76 2.81
185 173 1.80 2.63 68 2.38
177 82 3.21 3.61 88 3.32
174 81 3.10 4.16 74 4.06
188 69 2.51 2.78 90 3.59
232 89 3.21 3.45 93 3.39
217 81 2.98 3.88 76 3.47
297 79 2.90 3.76 77 3.59
223 43 2.04 2.39 85 3.35
22
TABLE III BLOODAND PULMONARYTEST DATA
SUBJ HGB
gm %
HCRT T-CHOL TRIG FEV-I







69 13.9 42 258 119 2.98 4.23 70 3.86
70 12.6 40 199 62 3.41 4.00 85 3.98
72 10.8 35 204 122 2.67 3.02 88 2.38
73 13.6 43 226 160 3.49 3.72 93 3.59
74 11.5 36 195 70 3.37 3.80 88 3.55
75 13.6 41 154 65 3.76 4.55 82 4.53
76 12.0 38 210 37 2.82 3.76 75 3.59
77 15.3 45 197 63 3.57 3.88 92 3.78
78 13.5 42 238 50 2.70 3.21 84 3.12
80 12.5 39 289 140 3.33 3.68 90 3.75
81 12.3 28 170 103 3.25 3.68 88 3.63
83 13.1 40 220 139 2.94 3.49 84 3.51
84 11.6 34 159 68 3.33 3.72 89 3.59
85 11.4 36 290 68 2.70 3.37 80 3.20
86 13.4 40 188 126 2.90 3.80 76 3.63
87 13.8 42 147 45 3.41 4.35 78 4.33
88 15.2 44 181 89
90 13.2 41 289 39 2.20 2.94 74 2.73
91 13.2 40 277 91 2.74 3.45 79 3.28
92 12.7 40 203 80 2.27 2.82 80 2.77
93 14.2 44 192 54 3.53 4.04 87 3.82
94 13.8 42 254 198 1.96 2.55 76 2.46
96 13.4 40 184 67 3.21 3.92 81 3.43
97 14.5 45 242 65 2.98 4.00 74 3.82
98 14.3 44 248 83 4.16 4.39 94 4.41
i00 14.1 42 244 97 2.74 3.57 76 3.39
i01 13.2 40 224 58 3.41 4.59 74 4.06
102 10.5 33 145 75 3.21 4.19 76 4.06
107 13.0 39 223 64 2.63 3.45 76 3.32
108 11.9 36 199 42 2.74 2.94 93 2.73
109 12.7 40 288 77 2.90 3.88 74 3.67
ii0 11.7 37 166 85 3.72 3.92 94 3.71
iii 14.2 44 178 57 3.80 4.66 81 4.45
112 11.9 36 179 160 3.41 3.70 90 3.20
113 12.3 38 207 86 3.76 4.70 80 4.57
115 12.6 38 288 184 2.94 3.61 81 3.47
116 13.1 40 158 97 3.25 4.12 78 4.02
117 14.1 43 234 106 3.57 4.16 85 4.02
118 13.3 40 245 141 4.08 4.47 91 4.33
123 13.3 42 261 167 3.25 3.88 83 3.67
124 13.5 42 207 92 2.98 3.53 84 3.28
127 13.5 42 169 126 2.86 3.49 81 3.35
144 13.2 41 214 144 2.16 3.37 64 3.43
146 11.9 37 179 108 2.78 3.37 82 3.28
147 12.9 39 252 73 3.41 4.23 80 3.98
153 13.4 40 180 77 3.18 3.88 81 3.67
155 12.8 39 223 72 3.02 4.12 73 3.86
156 12.0 37 160 39 3.53 4.00 88 3.78
158 12.8 40 212 89 3.37 4.12 81 3.82
23
TABLE IV LBNP TEST HEART RATE AND BLOOD PRESSURE DATA
SUBJ HR-SUP HR-MAX S-CLIN D-CLIN S-SUP D-SUP S-MAX D-MAX
bpm bpm mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg
1 77 86 103 66 99 62 97
4 86 106 116 86 106
5 71 79 103 58 89 58 93
6 90 103 108 60 104 58 iii
7 76 85 135 68 126 88 Iii
8 80 105 iii 67 107 77 95
9 73 88 106 60 100 68 100
15 69 93 94 65 86 61 77
16 70 86 90 70 87 60 103
18 78 112 102 52 91 52 80
19 93 112 110 70 104 72 98
20 54 61 99 72 97 72 96
21 70 88 104 74 108 73 I01
23 63 70 98 60 95 66 95
24 78 82 102 62 96 56 72
25 95 105 110 70 109 55 103
26 74 89 I01 81 98 77 95
27 85 96 95 60 99 65 97
28 73 95 105 70 105 65 94
29 80 108 II0 70 108 66 98
31 88 99 ii0 80 114 72 95
32 87 107 120 70 109 68 103
33 75 97 80 55 84 55 76
34 74 94 95 65 90 54 81
35 63 73 125 80 115 75 103
36 55 60 95 60 96 59 97
38 73 80 115 80 99 77 94
41 62 76 95 60 96 52 85
43 86 101 118 80 117 73 I00
48 54 70 80 55 83 51 76
49 72 _74 120 80 118 79 113
50 96 103 120 85 118 77 107
51 74 88 100 75 94 57 89
52 83 98 118 _ 90 119 79 109
53 84 101 120 80 116 81 100
54 76 87 ii0 76 100 59 91
56 77 95 I00 75 87 62 76
57 81 97 95 70 93 68 92
58 70 88 104 70 105 69 98
59 72 79 105 70 106 72 97
60 67 67 120 80 113 80 113
61 79 79 120 80 113 89 iii
62 74 74 98 70 94 56 91
63 76 82 II0 80 104 67 99
64 91 117 105 75 105 64 97
65 60 60 140 90 137 91 131
66 71 83 120 80 113 82 108
67 59 72 II0 80 97 73 93



















































TABLE IV LBNP TEST HEART RATE AND BLOOD PRESSURE DATA
SUBJ HE-SUP HE-MAX S-CLIN D-CLIN S-SUP D-SUP S-MAX D-MAX
bpm bpm mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg
69 57 64 150 85 89 70 96 74
70 72 76 108 70 99 72 96 71
72 69 89 108 60 96 67 85 71
73 78 87 95 70 88 61 82 60
74 65 80 120 80 122 83 107 79
75 84 101 105 80 102 66 92 65
76 69 81 115 78 102 70 102 79
77 88 94 110 80 110 72 100 67
78 73 99 98 75 84 61 82 62
80 81 87 108 78 112 73 106 73
81 77 90 104 70 102 64 95 63
83 79 86 140 85 128 79 117 81
84 102 120 130 75 118 73 115 79
85 76 77 120 80 104 71 119 67
86 84 125 100 68 97 59 88 56
87 69 85 107 70 103 70 94 71
88 71 74 110 64 113 70 102 60
90 65 69 105 70 94 60 88 62
91 71 88 98 65 94 58 79 60
92 62 68 120 70 96 74 96 73
93 62 82 102 84 102 63 100 71
94 70 76 116 72 117 75 ii0 69
96 88 118 100 70 103 65 82 59
97 67 82 98 70 91 63 91 69
98 64 77 100 66 i01 54 93 55
100 53 77 80 60 78 59 66 52
I01 64 74 100 70 93 65 92 72
102 67 78 115 80 95 72 94 74
107 73 78 82 58 85 54 83 62
108 74 94 95 60 90 60 88 65
109 79 98 105 70 i01 66 90 63
Ii0 85 106 90 55 I00 56 105 64
Iii 95 105 95 60 98 55 91 58
112 65 70 110 70 118 73 104 70
113 64 74 98 70 100 58 102 67
115 72 86 130 80 119 79 113 82
116 64 72 88 60 86 55 80 58
117 75 103 II0 70 104 71 93 75
118 88 107 II0 70 102 70 93 73
123 65 70 I00 60 103 57 96 57
124 95 Ii0 105 65 105 62 82 53
127 82 85 88 50 91 47 78 43
144 79 106 118 70 114 67 109 71
146 63 72 100 60 92 71 81 60
147 69 91 98 65 101 67 87 62
153 62 71 95 60 87 59 80 59
155 80 98 105 75 105 69 102 73
156 61 90 92 58 87 63
158 66 79 95 68 89 61 82 64
25
TABLE V LBNP TEST PERFORMANCE DATA
SUBJ LCC
cm
RCC CHANGE LLV CHANGE RLV
cm % %
1 31.6 31.2 1.3 1.0
4 32.4 33.0 i.I I.I
5 36.1 37.0 .7 1.3
6 31.5 32.0 1.2 I.I
7 32.3 32.1 i. 6 .8
8 31.1 31.6 .4 .4
9 34.1 34.4 1.0 1.8
15 33.5 34.1 I.I 1.4
16 32.5 32.8 1.3 1.6
18 34.0 34.0 2.0 1.8
19 33.0 32.1 1.3 1.7
20 31.3 32.7 .4 1.0
21 38.9 38.8 1.8 1.5
23 32.3 31.0 .3 .9
24 31.3 31.7 i.i .9
25 28.5 29.2 .4 1.0
26 35.0 35.2 .6 I. 8
27 30.8 31.3 2.2 1.5
28 35.7 36.3 1.3 1.0
29 31.8 31.5 .9 2.3
31 34.2 33.5 .2 .6
32 36.8 36.2 1.3 1.0
33 33.1 33.6 2.0 2.6
34 29.1 29.3 I.i 1.0
35 37.2 37.5 3.4
36 34.9 34.7 3.3 1.7
38 32.4 32.6 . 6 i. 3
41 31.2 31.0 1.5 1.5
43 31.3 31.4 1.7 1.4
48 32.0 31.6 2.8 3.7
49 35.4 35.5 1.3 1.6
50 33.5 34.6 I. 1 .7
51 34.7 33.9 .9 i. 2
52 40.2 40.9 2.0 1.7
53 32.9 33.1 .7 . 9
54 34.4 33.8 I.i 1.9
56 36.1 36.1 1.0 .8
57 30.6 31 .0 i. 8 I. 8
58 36.2 36.2 2.0 1.9
59 33.5 33.7 .5 .6
60 36.7 36.9 1.3 1.0
61 32.2 33.0 2.6 i. 7
62 32.3 31.2 5.5 1.9
63 33.4 32.7 i. 2 I. 3
64 33.1 34.5 .9 I. 0
65 36.2 36.8 1.5 2.0
66 37.0 36.2 2.9 i. 6
67 36.2 36.3 i.i 2.4

















































TABLE V LBNP TEST PERFORMANCE DATA
SUBJ LCC RCC CHANGE LLV CHANGE RLV
cm cm % %
69 33.4 33.0 1.5 1.2
70 33.0 32.5 .3 .6
72 38.1 37.3 .8 1.4
73 33.0 33.3 .4 .8
74 35.4 35.7 .4 1.0
75 36.9 37.4 .6 1.2
76 36.1 36.4 1.4 1.5
77 32.7 33.4 2.6 1.7
78 33.5 34.4 .9 .7
80 36.7 36.4 1.0 1.3
81 33.9 34.0 i. 0 i. 1
83 36.5 35.9 2.8 1.9
84 36.3 36.0 1.4 1.2
85 34.2 33.8 1.2 .9
86 36.5 36.4 1.2 .9
87 34.9 35.1 .6 1.3
88 33.8 33.2 1.5 1.0
90 30.4 30.7 2.3 i.i
91 32.0 32.3 i. 5 I. 9
92 30.4 29.8 I. 7 i. 7
93 32.6 33.0 1.4 .8
94 32.6 31.7 1.7 2.8
96 32.2 32.6 i.i 1
97 33.8 33.8 .8 I.I
98 31.7 31.7 .8 2.0
100 31.7 31.7 .9 2.5
i01 35.7 35.4 1.3 1.6
102 40.5 40.4 1.0 .9
107 32.0 31.4 1.7 4.9
108 31.6 32.2 1.6 1.2
109 33.5 34.2 2.9 3.1
ii0 32.6 32.7 1.0 .7
III 35.3 36.0 1.0
112 35.5 36.3 1.3 .9
113 33.7 32.7 I.I .7
115 33.4 34.0 2.1 1.3
116 33.4 34.5 1.6 1.7
117 38.3 37.9 1.7 2.3
118 41.2 41.9 .9 .6
123 35.5 35.0 1.4 1.9
124 36.0 35.5 .3 .6
127 31.6 31.4 2.3 I.I
144 31.3 31.6 .9 1.2
146 32.6 33.1 1.0 1.3
147 37.8 38.3 1.2 1.0
153 33.0 32.6 1.5 2.0
155 37.0 36.5 .7 .9
156 33.3 34.0 2.6 3.3









































































































HR-STN HR-HYV HR-MAX HR-R2
bpm bpm bpm bpm
HR-R5 V-02 DUR EXER
bpm ml/kg/min min
96 138 180 94 92 7.0
95 181 125 108 8.0
89 100 161 119 94 22.3 7.0
99 120 177 123 106 12.0
80 183 97 89 19.1 7.0
93 98 184 118 102 26.8 9.0
75 187 116 96 28.7 6.0
70 108 182 110 95 19.5 8.0
93 135 167 116 95 28.4 10.0
109 137 182 121 104 31.2 12.0
122 134 176 134 121 20.8 9.0
60 105 171 124 94 25.2 9.0
71 90 179 119 99 22.7 8.0
79 110 180 136 111 10.0
95 156 194 157 122 31.0 10.0
139 148 198 150 138 30.4 12.0
91 146 185 137 114 26.2 10.0
96 106 157 120 103 22.4 7.0
76 126 182 120 100 28.7 8.0
93 141 212 117 98 36.8 14.0
96 147 193 124 106 31.3 11.0
112 148 199 140 108 31.1 11.0
86 117 182 132 106 32.3 11.0
92 122 170 104 86 21.8 7.0
73 92 173 112 89 20.8 9.0
63 97 180 113 87 33.2 12.0
83 150 187 126 104 27.1 9.0
88 120 193 128 102 32.6 11.0
121 169 189 145 124 33.1 11.0
70 118 189 124 97 11.0
89 113 191 134 111 27.9 10.0
110 140 184 140 112 36.5 10.0
94 155 174 129 109 37.7 11.0
87 141 186 146 124 35.6 8.0
114 143 204 141 126 41.5 11.0
86 144 194 121 109 30.9 10.0
102 120 174 142 97 32.9 8.0
92 145 181 101 99 29.5 9.0
91 148 191 149 105 27.9 12.0
83 135 174 149 112 23.6 9.0
71 108 166 111 96 20.5 7.0
73 86 163 124 95 22.0 8.0
75 128 155 101 89 21.8 8.0
93 165 185 114 105 32.1 9.0
117 170 187 98 125 35.2 10.0
63 108 171 120 111 37.6 11.0
109 175 198 178 132 32.6 10.0
63 109 165 132 83 32.0 10.0
78 105 153 108 94 26.1 7.0
28
TABLE Vl TREADMILL TEST HEART RATE AND OXYGEN USE DATA
SUBJ HR-SUP HR-STN HR-HYV HR-MAX HR-R2 HR-R5 V-02 DUR EXER


















































79 i00 163 144
92 133 182 164
92 118 186 164
88 Iii 178 159
70 118 177 145
98 135 183 158
81 143 188 145
96 130 200 166
95 140 192 170
89 140 191 171
90 156 178 145
76 130 173 130
121 160 191 180
83 112 170 147
107 148 194 166
89 131 192 165
82 150 173 142
71 98 171 109
84 138 192 115
70 132 153 i01
70 II0 202 II0
74 118 163 140
112 147 193 167
76 137 164 110
76 150 187 151
64 I00 163 125
82 138 172 139
79 132 182 141
81 130 184 149
87 119 175 147
100 156 179 164
106 190 195 165
113 180 186 158
76 138 177 157
74 146 161 126
85 139 160 140
76 160 184 150
90 155 188 159
104 154 184 123
73 136 180 138
162 176 110
145 170 196 157
83 130 180 159
61 108 169 144
82 96 166 137
79 135 182 123
94 135 186 109
80 130 181 120



















































TABLE VII TREADMILL TEST BLOOD PRESSURE DATA
SUBJ S-SUP D-SUP S'STN D-STN S-MAX D-MAX S-R2 D-R2
mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg
S-R5 D-R5
mm Hg mm Hg
1 98 63 105 75 112 29 103
4 96 75 117 77 158 77 173 91 142 76
5 80 71 103 72 160 70 169 60 116 61
6 Ii0 58 130 69 139 46 112 47
7 117 67 114 90 232 75 143 93 114 89
8 109 76 106 80 210 75 119 76 103 75
9 112 59 103 64 200 152 62 125 59
15 87 61 84 73 116 123 55 95 60
16 98 78 106 81 130 119 68 96 64
18 101 55 103 68 138 60 153 57 118 56
19 134 83 139 92 155 75 155 66 130 70
20 106 71 105 82 182 60 186 77 130 67
21 115 74 118 79 173 49 123 60
23 112 76 107 80 146 86 140 54 115 57
24 102 61 III 65 146 176 127 50
25 114 66 136 62 204 50 164 134 52
26 95 72 108 66 172 67 140 49 133 54
27 95 56 95 66 167 72 142 58 122 62
28 102 76 103 84 150 99 142 71 112 71
29 103 60 112 76 164 80 157 50 141 49
31 99 70 120 80 148 90 147 75 121 69
32 108 58 136 60 150 70 161 46 115
33 94 61 95 63 120 66 138 59 117 60
34 90 50 97 65 128 70 115 50 89 53
35 114 78 108 84 160 178 85 141 78
36 92 54 98 62 150 76 166 53 126 46
38 91 46 95 81 146 80 129 69 98 75
41 94 49 105 60 144 70 172 46 118 45
43 140 64 141 95 174 68 171 64 137 59
48 93 53 94 71 146 66 57 II0 59
49 108 73 140 92 190 96 184 68 135 68
50 119 82 115 88 130 84 177 89 131 72
51 101 70 iii 81 156 145 68 120 65
52 iii 60 123 91 144 94 157 62 138 61
53 110 74 116 80 166 92 159 57 125 66
54 108 68 116 70 158 84 170 60 161 61
56 90 56 100 72 140 80 120 60 108 60
57 90 63 97 59 150 74 120 58 89 59
58 95 64 91 80 156 80 156 80 135 65
59 II0 74 105 79 176 90 148 78 132 75
60 112 78 122 88 171 60 146 82 129 79
61 118 81 119 88 164 88 178 88 145 84
62 105 54 104 69 148 80 140 64 105 53
63 104 60 121 76 148 80 154 121 47
64 114 62 112 68 140 68 237 154
65 128 89 143 94 210 99 209 93 167 87
66 129 90 152 97 186 94 125 41 155 74
67 92 70 108 81 155 80 151 75 113 57
68 94 62 108 62 152 125 71 II0 68
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TABLE Vl I TREADMILL TEST BLOODPRESSUREDATA
SUBJ S-SUP D-SUP S-STN D-STN S-MAX D-MAX S-R2 D-R2
mm Hg mm Hg mm Hg mmHg mm Hg mm Hg mmHg mm Hg
S-R5 D-R5
mm Hg mm Hg
69 106 80 135 92 170 80 166 72 122 64
70 99 75 134 68 154 83 II0 64
72 100 70 104 66 162 154 68 126 68
73 97 62 97 67 130 126 70 123 63
74 122 79 123 84 144 165 59 134 63
75 102 64 107 80 150 86 138 84 124 58
76 108 86 118 89 178 86 148 86
77 113 52 102 80 130 70 145 80 122 78
78 81 62 88 68 160 70 140 80 III 64
80 107 62 IIi 84 158 80 147 66
81 ii0 78 118 76 158 131 62
83 113 79 125 86 140 150 45 150 70
84 125 77 161 87 173 160 50
85 iii 73 135 73 152 55 147 66
86 98 59 96 61 160 70 145 65 121 61
87 110 60 116 60 160 90 148 82 120 50
88 126 83 150 70 168 182 66
90 112 48 124 66 170 70 130 58 104 50
91 110 50 98 50 182 52 130 50
92 95 50 102 62 144 74 148 58 106 56
93 96 65 115 78 169 62 158 65 116 62
94 95 71 96 75 168 144 60 123
96 89 61 97 72 155 75 153 109 86
97 99 72 93 65 144 70 139 80 125 49
98 I01 54 113 65 170 74 140 60 137 52
100 82 59 91 69 132 61 132 61 IIi 63
I01 94 69 104 69 148 133 59 103 69
102 91 67 105 89 160 130
107 81 58 81 59 160 70 134 64 122 42
108 85 71 98 83 130 58 104 57
109 98 87 97 84 190 88 136 73 112 70
110 95 61 102 64 163 70 149 58 141 49
Iii 104 76 105 72 141 138 119 54
112 124 63 118 62 127 59
113 Iii 66 107 75 153 59 157 58 121 60
115 139 92 151 89 202 99 176 98 133 83
116 112 62 104 73 172 82 98 57
117 90 83 104 90 220 120 70
118 107 75 122 78 176 162 52 121 74
123 104 58 105 59 160 74 140 66 119 60
124 108 80 117 76 152 70 IIi 73
127 99 52 92 64 150 70 142 64 107 54
144 128 79 125 88 162 75 150 130 75
146 89 62 100 67 160 85 140 75 103 66
147 104 63 109 67 140 70 116 71
153 99 65 104 79 148 154 60 ii0 65
155 106 72 109 69 135 71 97 64
156 59 96 68 174 70 162 75 124 60
158 112 75 I01 58 154 70 144 62 107 59
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TABLE IX SUBJECT AND TEST DESCRIPTIVE DATA
(Repeat tests)
SUBJ TEST DATE AGE HEIGHT WEIGHT T-oral T-room


















10Dec76 50 165.0 55.3 98.0
130ct76 25 163.0 46.7 98.2
7Dec76 35 163.0 49.9 98.0
9Dec76 22 158.0 74.8 98.4
24Nov76 35 163.0 59.0 98.4
15Dec76 27 158.0 46.3 97.8
13Dec76 37 165.0 54.4 98.2
8Dec76 45 173.0 59.0 98.2
17Dec76 61 158.0 49.9 98.4
20Dec76 28 164.0 68.0 98.0
5Jan77 37 159.0 53.6 98.0
14Dec76 23 165.0 54.0 97.8
19Nov76 24 163.0 48.5 98.0
6Jan77 32 168.0 53.5 98.0
2Dec76 24 165.0 56.2 98.4
15Mar77 33 163.6 52.6 97.8




















17 17.0 17.0 17.0 16.0
33.6 163.4 55.7 98.1 73.3


















12Apr77 51 160.7 58.2 97.8
13Apr77 25 165.1 48.0 98.0
14Apr77 35 160.2 52.3 98.0
19Apr77 23 158.0 81.3 97.8
19Apr77 36 164.0 60.0 97.8
20Apr77 27 158.0 44.3 97.8
20Apr77 37 164.0 54.8 98.0
21Apr77 45 173.5 62.1 97.6
26Apr77 61 157.8 50.0 97.6
27Apr77 28 166.8 70.1 97.8
28Apt77 38 160.0 53.0 98.0
4May77 24 165.5 56.1 98.8
5May77 25 162.3 48.1 98.6
29Mar77 31 165.5 52.0 98.0
29Mar77 24 165.0 57.5 97.8
29Mar77 33 160.5 54.4 99.2





















17 17.0 17.0 17.0 17
33.9 162.7 56.8 98.1 72






















TABLE X SUBJECT AND TEST HISTORICAL DATA
(Repeat Tests)
SUBJ MENSTRUAL HISTORY MEDICATIONS LIFE STYLE
Cycle day/length/none smoke exer
SLEEP/EAT TIME
Hours Hours
22 HY-12 estrog, diur 1 1 5.5 2.0
1 25 28 8.5 12.0
19 12 30 2 1 11.0 1.5
21 30 31 1 6.5 10.5
9 21 30 1 2 8.5 14.0
25 18 30 2 1 7.5 14.0
23 14 30 1 2 5.5 2.0
20 PM-I.5 2 1 6.0 16.0
27 PM-5 1 1 7.0 1.5
28 14 30 1 2 6.0 12.5
33 14 30 1 2 7.0 5.0
24 ii 30 2 2 6.0 12.0
6 II 28 2 2 7.0 11.5
34 33 35 1 2 7.0 10.0
15 16 30 2 1 7.0 14.0
107 14 32 1 2 6.0 11.0
68 7 28 1 2 7.0 ii.0
N 14 14 16 15 17.0 17.0
Mean 17 30 1 2 7.0 9.4


























1 1 6.0 2.5
2 2 7.0 12.0
2 1 6.0 13.0
1 8.5 14.0
1 2 7.0 14.0
2 1 5.0 12.0
1 2 5.0 3.0
2 1 6.0 11.0
1 2 7.0 2.0
1 2 6.5 12.0
1 2 6.0 13.0
2 2 8.0 20.0
2 2 8.5 2.5
1 2 7.0 15.0
2 1 7.5 2.0
1 2 5.0 5.0
2 8.0 16.0
17 15 17.0 17.0
1 2 6.7 9.9


























BLOOD AND PULMONARY TEST DATA
(Repeat tests)
T-CHOL TRIG FEV-I FVC
mg % mg % L L
40 217 89
39 175 116 3.10 3.61
38 227 43
39 147 108 2.16 2.63
40 149 63 3.25 3.88
38 226 61 2.55 2.70
40 149 65 2.86 3.25
32 175 52 3.57 3.88
41 150 100
41 165 95 2.86 3.37
41 239 93 2.63 3.33
40 163 51 3.76 4.08
41 247 59 3.08 3.52
44 167 54 3.57 4.19
40 215 78 3.25 3.65
39 223 64 2.63 3.45

















17 17 17 14.00 14.00 14 14.00
40 191.6 73 2.95 3.42 86 3.37
2 36.2 23 .52 .54 5 .42
142







157 12.8 40 212 89
159
161 12.7 39 233 77
164
165
119 13.7 43 178 50
120 12.7 40 156 57
122 12.7 41 214 107
125 12.6 39 203 51
N 7.0 7 7 7
Mean 12.8 40 201.4 74
SD .6 2 31.8 27
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TABLE XIl LBNP TEST HEART RATE AND BLOOD PRESSURE DATA
(Repeat tests)
SUB HR-SUP HR-MAX S-CLIN D-CLIN S-SUP D-SUP S-MAX D-MAX


















110 70 103 75 95 75
103 66 99 62 97 63
ii0 70 104 72 98 74
104 74 108 73 i01 73
106 60 100 68 I00 71
ii0 70 109 55 103 57
98 60 95 66 95 70
99 72 97 72 96 73
95 60 99 65 97 68
105 70 105 65 94 68
80 55 84 55 76 56
102 62 96 56 72 54
108 60 104 58 III 71
95 65 90 54 81 55
94 65 86 61 77 61
82 58 85 54 83 62




17 17 17 17 17 17
99.5 64.5 97.5 63.2 91.7 65.8





















100 60 90 58 84 61
95 60 89 54 94 56
98 56 98 64 85 59
108 70 107 66 91 58
108 70 101 69 96 70
95 65 I00 62 92 59
90 55 83 56 86 59
110 70 88 58 89 61
90 60 88 57 59 41
I00 65 92 62 90 68
84 44 83 51 76 53
94 51 86 44
90 60 96 51 103 63
88 50 81 51 73 52
90 50 78 51 70 50
80 56 88 52 89 51
98 60 93 61 84 61
16 16 17 17 17 17
95.3 59.4 91.1 57.3 85.1 56.8














22 34.4 34.5 2.1 1.7 7299
1 31.6 31.2 1.3 1.0
19 33.0 32.1 1.3 1.7 6677
21 38.9 38.8 1.8 1.5 5054
9 34.1 34.4 1.0 1.8 8310
25 28.5 29.2 .4 1.0 5899
23 32.3 31.0 .3 .9 7035
20 31.3 32.7 .4 1.0 6945
27 30.8 31.3 2.2 1.5 6934
28 35.7 36.3 1.3 1.0 7848
33 33.1 33.6 2.0 2.6 6688
24 31.3 31.7 1.1 .9 6210
6 31.5 32.0 1.2 1.1
34 29.1 29.3 1.1 1.0 5740
15 33.5 34.1 1.1 1.4 7385
107 32.0 31.4 1.7 4.9 6533
68 34.6 35.4 .6 .5 7969
N 17.0 17 17 17 15
Mean 32.7 32.9 1.2 1.5 6835
SD 2.5 2.5 .6 1.0 880
142 34.2 34.5
143 32.0 31.9 1.6 .4
145 34.0 32.8 1.3 1.5
148 39.0 38.7 2.1 2.2
149 35.1 34.9 1.4 1.6
150 29.1 29.2 1.9 1.6
151 32.4 31.0 .3 1.0
152 31.3 32.2 .9 .9
157 31.6 31.5 1.4 .4
159 35.5 36.0 1.9 .8
161 33.3 33.5 2.5 3.0
164 32.1 32.6 5.0 2.7
165 32.1 32.3 3.4 1.6
119 29.0 29.1 .8 .9
120 34.3 34.7 .4 1.3
122 32.5 32.0 .7 1.1






















































TREADMILL TEST HEART RATE AND
(Repeat Tests)
OXYGEN USE DATA
HR-STN HR-HYV HR-MAX HR-R2 HR-R5 V-02 DUR EXER
bpm bpm bpm bpm bpm ml/kg/min min
65 91 151 101 86 9.0
96 138 180 94 92 7.0
122 134 176 134 121 20.8 9.0
71 90 179 119 99 22.7 8.0
75 187 116 96 28.7 6.0
139 148 198 150 138 30.4 12.0
79 II0 180 136 IIi 10.0
60 105 171 124 94 25.2 9.0
96 106 157 120 103 22.4 7.0
76 126 182 120 100 28.7 8.0
86 117 182 132 106 32.3 11.0
95 156 194 157 122 31.0 10.0
99 120 177 123 106 12.0
92 122 170 104 86 21.8 7.0
70 108 182 110 95 19.5 8.0
81 130 184 149 103 33.4 Ii.0
78 105 153 108 94 26.1 7.0
17 16 17 17 17 13 17
87 119 177 123 103 26.4 8.9





















63 160 120 92 29.0 9.4
80 188 112 109 35.0 10.0
102 132 168 151 112 34.9 7.7
73 140 189 131 108 26.3 Ii.0
90 140 204 125 120 41.7 13.5
98 145 202 162 138 37.4 13.6
70 120 214 115 42.4 10.8
72 108 176 132 99 30.0 II.0
105 108 171 148 124 30.1 8.0
88 150 176 118 99 30.0 7.6
79 114 182 129 105 34.9 II.0
90 204 168 128 39.3 12.6
88 126 191 130 103 32.5 15.7
96 120 161 107 86 25.1 7.5
81 146 190 173 iii 29.4 9.3
92 140 182 142 114 31.0 10.0
81 130 185 158 108 36.2 9.8
17 14 17 16 17 17 17
85 130 185 138 110 33.2 10.5





mm Hg mm Hg
TREADMILL TEST BLOOD PRESSURE DATA
(Repeat Tests)
S-STN D-STN S-MAX D-MAX S-R2 D-R2
mm Hg mm Hg mm Hg mm Hg mm Hg mm Hg
22 99 73 89
1 98 63 105
19 134 83 139
21 115 74 118
9 112 59 103
25 114 66 136
23 112 76 107
20 106 71 105
27 95 56 95
28 102 76 103
33 94 61 95
24 102 61 iii
6 ii0 58 130
34 90 50 97
15 87 61 84
107 81 58 81
68 94 62 108
N 17 17 17
Mean 103 65 106
SD 13 9 17
S-R5 D-R5
mm Hgmm Hg
81 158 70 151 84 119 78
75 112 29 103
92 155 75 155 66 130 70
79 173 49 123 60
64 200 152 62 125 59
62 204 50 164 134 52
80 146 86 140 54 115 57
82 182 60 186 77 130 67
66 167 72 142 58 122 62
84 150 99 142 71 112 71
63 120 66 138 59 117 60
65 146 176 127 50
69 139 46 112 47
65 128 70 115 50 89 53
73 116 123 55 95 60
59 160 70 134 64 122 42
62 152 125 71 ii0 68
17 14 I0 17 15 17 17
72 156 72 145 60 117 56
I0 26 13 21 14 12 17
142 73 60 88
143 100 59 107
145 106 68 129
148 104 70 100
149 105 70 II0
150 107 65 101
151 90 62 103
152 98 71 105
157 87 57 100
159 97 73 94
161 87 58 96
164 97 54 98
165 105 55 i00
119 89 70 91
120 84 54 89
122 90 57 96
125 i00 66 132
N 17 17 17
Mean 95 63 102
SD 10 7 13
58 150 70 112 70
68 125 65 132 50 119 59
66 155 50 129 64
72 160 114
70 172 88 141 75 128 60
63 140 72 163 61 145 53
66 122 60 122 65
87 180 70 169 72 119 68
71 144 62 159 54 127 67
74 131 79 i01 78
138 68 127 57 114 59
63 166 70 158 52 148
78 150 60 137 65 104 48
72 132 76 122 76
63 164 63 148 50 125 55
66 140 78 128 70 121 58
68 158 62 144 60 122 60
16 16 15 13 13 16 14
69 150 68 143 63 122 62





















































XVI LBNP TEST SYSTOLIC TIME INTERVALS
PEP/LVET HR-INST
Rest MaxLBNP Rest MaxLBNP
.393 .512 86 i01
.337 .317 72 71
.236 .287 90 108
.224 .404 73 94
.330 .423 72 117
.278 .387 73 99
.263 .565 67 109
.343 .620 71 90
.275 .537 78 120
.320 .442 92 112
.339 .353 55 63
.224 .404 73 94
.332 .405 61 70
.298 .272 77 79
.381 .622 84 106
.345 .520 75 87
.282 .442 79 97
.384 .524 70 105
.272 .472 78 115
.301 .448 82 I01
.263 .431 86 107
.242 .490 75 105
.267 .399 71 90
.362 .510 60 78
.243 .325 54 56
.323 .348 71 78
.276 .485 58 75
.247 .447 79 106
.375 .480 53 69
.262 .404 73 76
.340 .444 96 102
.377 .514 68 82
.220 .342 79 102
.289 .428 81 103
.267 .377 71 90
.381 .393 79 i01
.313 .487 79 i00
.268 .440 68 88
.304 .260 70 78
.343 .442 78 89
.250 .339 70 74
.271 .400 76 77
.348 .508 91 118
.242 .403 63 60
.316 .485 72 86





















































XVI LBNP TEST SYSTOLIC TIME INTERVALS
PEP/LVET HR-INST
Rest MaxLBNP Rest MaxLBNP
.280 .348 55 63
.281 .424 73 81
.227 .329 69 89
.335 .452 79 91
.313 .349 63 80
.310 .447 83 ii0
.343 .461 68 85
.258 .399 71 i00
.288 .442 74 108
.280 .379 74 84
.283 .412 75 88
.281 .448 78 86
.230 .282 104 120
.238 .298 79 81
.301 .412 63 84
.323 .402 72 74
.246 .363 63 70
.232 .309 64 84
.277 .417 60 67
.324 .508 62 86
.269 .341 70 78
.247 .471 84 119
.299 .386 68 83
.283 .396 66 85
.274 .438 54 82
.378 .491 62 75
.360 .410 65 79
.357 .454 75 81
.295 .393 76 i01
.289 .480 81 109
.274 .424 85 ii0
.228 .390 94 i01
.263 .390 64 80
.223 .311 63 75
.305 .413 70 88
.185 .396 65 72
.235 .382 90 Iii
.251 .349 68 67
.401 .524 95 115
.224 .298 80 87
.326 .426 79 129
.280 .456 63 77
.327 .446 71 94
.313 .407 59 73
.247 .374 82 I01
.266 .542 59 99





















































XVII TREADMILL TEST SYSTOLIC TIME INTERVALS
PEP/LVET HR-INST
Pre-TMX Post Pre-TMX Post
.210 .415 69 105
.306 .209 78 134
.248 .793 108 135
.285 .546 55 122
.205 .475 65 130
.270 .134 59 128
.309 .527 77 154
.278 .370 84 157
.263 .186 82 116
.335 .458 69 121
.248 .312 82 152
.206 .316 84 121
.223 .554 74 132
.271 .317 71 112
.311 .197 57 120
.327 .189 71 135
.206 .330 64 115
.332 .281 52 137
.274 .223 68 147
.329 .422 86 137
.301 .764 67 116
.349 .307 80 139
.318 .354 91 142
.259 .220 71 ii0
.371 .213 81 i01
.286 .553 65 i01
.299 .458 78 115
.240 .166 74 I00
.252 .220 77 120
.312 .215 95 121
.256 .232 59 114
.301 81
.329 .207 51 109
42
TABLE XVII TREADMILL TEST SYSTOLIC TIME INTERVALS
SUBJ PEP/LVET HR-INST



































































































100 x (MAX-REST REFERENCE)/REST REFERENCE
SYSTOLIC BP DIASTOLIC BP STI RATIO



















































-9 35 -2 30
4 55 9 -3 -6
7 22 22
-12 104 -5 -17 80
-ii 98 -14 -6 28
94 4 39
-IO 38 115
18 23 22 81 98
-12 34 -2 -12 95 -32
-6 12 3 -18 38 220
-I 73 1 -27 4 92
-6 80 132
36 6 8 22 -50
-25 32 -4 -9 71
-6 50 4 -19 63 33
-3 59 -8 2 51
-2 76 5 9 57 -29
-10 46 5 18 36 37
-9 46 -8 5 74 26
-17 23 -4 13 49
-6 I0 6 17 64 53
-10" 26 2 5 102 148
-10 32 2 8 49 17
-I0 48 41 -37
1 53 7 23 34
-5 54 -8 -I 8 -42
-ii 37 -8 17 76 60
-15 23 -8 -28 81
-8 55 2 -7 28 -15
-4 36 4 54 -19
-9 13 -5 -5 31 28
-5 41 25 36 154
-8 17 4 3 55 -12
-14 43 -6 15 48 Ii
-9 36 2 20 41 -15
-13 40 5 II 3
-i 55 25 56 -43
-7 71 3 64 93
-8 68 1 14 -14
40 8 -32
-2 38 -13 29 53
-3 42 5 16 36 -31
-5 22 5 48 -13
-8 25 3 46 -31
-4 47 2 5 67 -9
-4 22 2 -3 53
-4 44 -4 -I 13 -37
-ii 41 6
44




i00 x (MAX-REST REFERENCE)/REST REFERENCE
SYSTOLIC BP DIASTOLIC BP STI RATIO


















































8 26 6 -13 24 223
-3 15 -i 22 51
-ii 56 6 45 -6
-7 34 -2 35 -31
-12 17 -5 12 -27
-10 40 -2 8 44 -21
13 34 -41
-9 27 -7 -13 55 31
-2 82 2 3 53 -36
-5 35 25
-7 34 -2 46 -Ii
-9 12 3 59 8
-3 7 8 23 1
14 -6 25
-9 67 -5 15
-9 38 1 50 37
-i0 12 -14 24 79
-6 37 3 6 48 14
-16 3 33 -i0
41 -i 19 51
-2 47 13 -21 57 -41
-6 75 -8 27 60
-20 60 -9 4 91 -13
55 10 8 29 -8
-8 50 2 14 40 -I
-15 45 -12 -12 60 -8
-I 42 ii 30 -46
-I 52 3 14 -31
-2 98 15 19 27 -34
-2 8 33 -22
-II 96 -5 5 66 6
5 60 14 9 55 -32
-7 34 5 71 89
-12 -4 48 -9
2 43 16 -21 39 -36
-5 34 4 ll 35 -45
-7 65 5 12 114
-Ii 112 6
-9 44 4 63 7
-7 52 25 39 15
-22 30 -15 -8 31 -41
-14 63 -9 9 33 194
-4 30 6 -15 31 -28
-12 60 -15 27 63 26
-14 -7 36 -16
-8 42 30 -44
-3 6 51 -9
-5 81 9 3 104 -22
-8 52 5 21 51 -48
45
TABLE XIX DOUBLEPRODUCTS
SUBJ DPSUNP DPSUTM DPLBNP DPSTN DPTMX DP2 DP5
1 7623 6566 8342 10080 10528 9476
4 9976 7008 11236 11115 28598 21625 15336
5 6319 5760 7347 9167 25760 20111 10904
6 9360 8910 11433 12870 17097 11872
7 9576 9828 9435 9120 42456 13871 10146
8 8560 9592 9975 9858 38640 14042 10506
9 7300 7840 8800 7725 37400 17632 12000
15 5934 5568 7161 5880 21112 13530 9025
16 6090 6664 8858 9858 21710 13804 9120
18 7098 7777 8960 11227 25116 18513 12272
19 9672 13936 10976 16958 27280 20770 15730
20 5238 5830 5856 6300 31122 23064 12220
21 7560 7820 8888 8378 20587 12177
23 5985 6720 6650 8453 26280 19040 12765
24 7488 8160 5904 10545 28324 27632 15494
25 10355 9690 10815 18904 40392 24600 18492
26 7252 7220 8455 9828 31820 19180 15162
27 8415 7600 9312 9120 26219 17040 12566
28 7665 6936 8930 7828 27300 17040 11200
29 8640 8240 10584 10416 34768 18369 13818
31 10032 7326 9405 11520 28564 18228 12826
32 9483 9396 11021 15232 29850 22540 12420
33 6300 6674 7372 8170 21840 18216 12402
34 6660 6480 7614 8924 21760 11960 7654
35 7245 7068 7519 7884 27680 19936 12549
36 5280 4600 5820 6174 27000 18758 10962
38 7227 7520 7885 27302 16254 10192
41 5952 6204 6460 9240 27792 22016 12036
43 10062 11480 10100 17061 32886 24795 16988
48 4482 4743 5320 6580 27594 10670
49 8496 7236 8362 12460 36290 24656 14985
50 11328 9877 11021 12650 23920 24780 14672
51 6956 6666 7832 10434 27144 18705 13080
52 9877 9102 10682 10701 26784 22922 17112
53 9744 10340 10100 13224 33864 22419 15750
54 7600 7452 7917 9976 30652 20570 17549
56 6699 6930 7220 10200 24360 17040 10476
57 7533 7560 8924 8924 27150 12120 8811
58 7350 6080 8624 8281 29796 23244 14175
59 7632 7480 7663 8715 30624 22052 14784
60 7571 7616 7571 8662 28386 16206 12384
61 8927 8378 8769 8687 26732 22072 13775
62 6956 7560 6734 7800 22940 14140 9345
63 7904 8528 8118 11253 27380 17556 12705
64 9555 10146 11349 13104 26180 23226 19250
65 8220 7936 7860 9009 35910 25080 18537
66 8023 10707 8964 16568 36828 22250 20460
67 5723 5244 6696 6804 25575 19932 9379
68 6696 6674 7553 8424 23256 13500 10340
46
TABLE XIX DOUBLEPRODUCTS
SUBJ DPSUNP DPSUTM DPLBNP DPSTN DPTMX DP2 DP5
69 5073 6254 6144 10665 27710 23904 11102
70 7128 7425 7296 12328 28028 13420
72 6624 6700 7565 9568 30132 25256 13734
73 6864 7954 7134 8536 23140 20034 13407
74 7930 7808 8560 8610 25488 23925 12730
75 8568 8160 9292 10486 27450 21804 14508
76 7038 7236 8262 9558 25810 15984
77 9680 8362 9400 9792 26000 24070 15250
78 6132 5508 8118 8360 30720 23800 12654
80 9072 8346 9222 9879 27018 18228
81 7854 8800 8550 10620 28124 13886
83 10112 7797 10062 9500 24220 19500 14100
84 12036 14750 13800 19481 33043 20960
85 7904 8214 9163 11205 22344 15582
86 8148 8134 11000 10272 31040 24070 13310
87 7107 7480 7990 10324 30720 24420 13920
88 8023 8442 7548 12300 29064 17836
90 6110 6608 6072 8804 29070 14170 8320
91 6674 7150 6952 8232 20930 12740
92 5952 6080 6528 7140 22032 14948 8798
93 6324 5760 8200 8050 34138 17380 11368
94 8190 6460 8360 7104 27384 20160 11562
96 9064 7476 9676 10864 29915 25551 11881
97 6097 6534 7462 7068 23616 15290 12750
98 6464 6464 7161 8588 31790 21140 13289
100 4134 4018 5082 5824 21516 16500 8103
i01 5952 6016 6808 8528 25456 18487 9167
102 6365 5642 7332 8295 29120 18330
107 6205 5832 6474 6561 29440 19966 12566
108 6660 6460 8272 8526 19110 10816
109 7979 6762 8820 9700 34010 22304 12096
ii0 8500 7600 11130 10812 31785 24585 15510
Iii 9310 10504 9555 11865 26226 21804 14280
112 7670 8556 7280 8968 14351
113 6400 6882 7548 7918 24633 19782 11374
115 8568 11398 9718 12835 32320 24640 13832
116 5504 7168 5760 7904 31648 8918
117 7800 7290 9579 9360 41360 13440
118 8976 9416 9951 12688 32384 19926 13915
123 6695 8320 6720 7665 28800 19320 11186
124 9975 9828 9020 26752 11544
127 7462 9405 6630 13340 29400 22294 13054
144 9006 10240 11554 10375 29160 23850 13260
146 5796 4806 5832 6100 27040 20160 7725
147 6969 7072 7917 8938 19180 11600
153 5394 6138 5680 8216 26936 18942 11660
155 8400 9434 9996 10246 14715 9894
156 5612 7830 7680 31494 19440 12524








body surface area (sq m) 98
oral temp. (deg F) 98
room temp. (deg F) 96
menst, cycle length (days) 71
day of menst, cycle 71
amt. of sleep (hrs) 98
time since eating (hrs) 98
hgb (gm %) 98
hct (%) 98
cholesterol (mg %) 98





SBP, clinical (mm Hg) 96


































































TABLE A2 : SIGNIFICANT CORRELATIONS BETWEEN DESCRIPTIVE





age SBP, clinical 0.42
oral temp. -0.009
room temp. -0.04











height weight 0.54 -29.49




weight body surface area 0.01 0.86
SBP, clinical 0.35 85.68










SBP, clinical 27.04 61.35
DBP, clinical 20.83 35.67
cycle length DBP, clinical -1.04 98.98
hgb hct 2.66 5.07





FVC VC 0.84 0.48
FEVI/FVC VC -0.02 5.13













































N Mean SE Min Max
HR, supine (bpm)
HR, maximal (bpm)
SBP, supine (mm Hg)
DBP, supine (mm Hg)
SBP, maximal (mm Hg)
DBP, maximal (mm Hg)
PEP/LVET, rest
PEP/LVET, maximal
left calf circ. (cm)




































Variable Slope Intercept r
HR, supine SBP, supine 0.36 75.34 .33
change RLV -0.02 2.90 -.29
HR, maximal 1.17 1.42 .84
HR, maximal
SBP, supine
PEP/LVET, maximal 0.002 0.29 .29
DBP, supine 0.62 4.15 .75
SBP, maximal 0.85 8.67 .83
DBP, maximal 0.52 14.72 .65
left calf circ. 0.05 28.75 .24
right calf circ. 0.05 28.69 .24
LLV 22.62 5143.00 .22
DBP, supine SBP, maximal 0.86 37.85 .69
DBP, maximal 0.82 12.37 .85
left calf circ. 0.08 28.71 .30
right calf circ. 0.08 28.46 .32
LLV 36.34 5014.69 .29
SBP, maximal DBP, maximal 0.60 10.55 .77
left calf circ. 0.04 29.94 .20
LLV 22.00 5355.77 .22
DBP, maximal left calf circ. 0.11 26.81 .39
right calf circ. 0.II 26.75 .40
LLV 50.73 4029.23 .40




left calf circ. right calf circ. 0.98 0.79 .97





LLV 355.09 -4664.42 .76
HR, maximal -4.07 93.75 -.20
change RLV 0.41 0.86 .46
change RLV -0.0001 2.52 -.23
51





HR, 2-min rec. (bpm)
HR, 5-min rec. (bpm)
SBP, supine (mm Hg)
DBP, supine (mm Hg)
SBP, standing (mm Hg)
DBP, standing (mm Hg)
SBP, maxlmal (mm Hg)
DBP, maxlmal (mm Hg)
SBP, 2-min rec. (mm Hg)
DBP, 2-min rec. (mm Hg)
SBP, 5-min rec. (mm Hg)







































































































SIGNIFICANT CORRELATIONS BETWEEN TREADMILL TEST
VARIABLES (p < 0.05)
Dependent
Variable Slope Intercept r
SBP, supine 0.33 80.53 .31
SBP, standing 0.44 79.11 .33
SBP, standing 0.21 92.94 .21
PEP/LVET, maximal 0.002 0.14 .23
V02 peak 0.06 22.05 .22
V02 peak 0.26 -17.14 .51
V02 peak 0.12 14.61 .38
SBP, 5-min rec. 0.53 67.42 .39
V02 peak 0.17 12.66 .33
HR, 5-min rec. 0.34 68.72 .34
HR, 5-min rec. 0.24 88.04 .20
HR, 5-min rec. 0.28 73.32 .35
HR, 5-min rec. 0.15 81.30 .25
V02 peak 0.10 17.70 .28
HR, maximal 3.42 148.87 .57
HR, 5-ein rec. 1.56 89.69 .25
SBP, 2-min rec. 2.52 127.03 .25
DBP, 5-min rec. -1.42 76.45 -.28
V02 peak 2.09 II.01 .66
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TABLE D: SIGNIFICANT CORRELATIONSBETWEENLBNP TEST VARIABLES
AND SELECTEDDESCRIPTIVE VARIABLES (p < 0.05)
Independent Dependent
Variable Variable Slope Intercept r
age HR, supine -.25 82.66 -.24
HR, maximal .52 105.69 -.37
DBP, supine .25 58.14 .27
SBP, maximal .31 84.43 .27
DBP, maximal .26 58.35 .30
height left calf circ. .09 18.56 .23
right calf circ. .09 18.90 .22
LLV 89.50 -7309.03 .43
weight left calf circ. .24 19.53 .82
right calf circ. .24 19.76 .81
LLV 100.43 1389.84 .73
SBP, supine .35 80.42 .24
DBP, supine .34 46.61 .30
DBP, maximal .42 41.72 .37
oral temp. HR, supine 8.29 -738.72 .28
HR, maximal 9.74 -867.62 .24
room temp. DBP, supine -1.12 148.02 -.21
menstrual day DBP, maximal -9.43 71.06 -.25
54
TABLE E : SIGNIFICANT CORRELATIONS BETWEEN TREADMILL TEST









































TABLE F : SELECTED SIGNIFICANT CORRELATIONS BETWEEN TREADMILL


































SBP, maximal SBP, standing .90 25.94 .65
DBP, maximal DBP, standing .74 24.54 .64

















TABLE G: SUMMARY STATISTICS ON DOUBLE PRODUCTS
Variable N Mean Std Error Minimum Maximum
DP, supine before LBNP
DP, supine before TMX
DP, at maximal LBNP
DP, at quiet standing
DP, at maximal exercise
DP, 2 minutes after TMX
DP, 5 minutes after TMX
98 7581.6 155.60 4134 12036
96 7705.0 183.45 4018 14750
98 8352.1 169.15 5082 13800
97 9850.8 268.53 5824 19481
88 28856.5 479.43 21112 42456
89 20020.6 398.13 10528 27632












SBP, sitting (mm Hg)




OF NASA WOMEN ASTRONAUTS
DESCRIPTIVE VARIABLES
N Mean SD S M Max
13 36.1 4.10 1.18 28 44
13 166.5 5.33 1.54 157 175
13 59.5 8.07 2.33 47 74
14 13.0 1.07 .30 ii.0 15.8
14 38.0 2.70 .75 34 45
14 182.8 34.75 9.64 123 250
14 3.2 .52 .14 1.9 4.2
14 75.0 32.33 8.97 41 172
12 105.2 5.97 1.80 98 118
12 67.5 5.90 1.78 60 80
i0 171.6 7.30 2.43 162 185
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